护佑品牌怎么样 申请店铺

我要投票 护佑在医疗用品行业中的票数:6 更新时间:2024-11-22
护佑是哪个国家的品牌?「护佑」是 扬子江药业集团有限公司 旗下著名品牌。该品牌发源于江苏省泰州市,由创始人徐镜人在2001-03-27期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
护佑怎么样

创建于1971年,拥有中西药并举,处方药与非处方药并重的产品体系,产学研/科工贸一体化的创新型医药企业集团


扬子江药业集团创建于1971年,是一家跨地区、产学研相结合、科工贸一体化的国家大型医药企业集团。集团总部位于江苏省泰州市,现有员工15000人,总占地面积300多万平方米。旗下15家成员公司分布泰州、北京、上海、南京、广州、成都、苏州、常州等地;营销网络覆盖除台湾以外的全国各省、市、自治区。

扬子江药业集团把研发创新作为企业发展战略基点,致力于国家一类新药和创新药物的研发。集团坚持不懈走创新之路,在新药研发上,全面推进“三药并举”战略,以每年按销售额3~4%比例投入新药研发,抢占科技制高点,引进具有国际视野的高端研发创新人才,建立国际化研发体系。目前在研的化学创新药、仿制药、中药和生物药达100多个,确保了短期、中期和长期产品研发有序进行。经过多年的积累和创新,产品体系覆盖10多个领域、10多种剂型、200多个品规。集团一直以市场为导向,研发产品以抗感染、心脑血管、消化系统为主,并积极开拓其它具有增长潜力的用药市场,形成“研发一批、生产一批、储备一批”的产品梯队,有力保证了企业的持续健康发展。

集团根据中医泰斗董建华院士等名老中医的验方,相继成功研发并上市胃苏颗粒、荜铃胃痛颗粒、蓝芩口服液、双花百合片、香芍颗粒、百乐眠胶囊、黄芪精口服液、柴芩清宁胶囊、青乳消颗粒、补肾润肺口服液、神曲消食口服液等一大批疗效独特的中药精品,为无数患者送去健康福音。正在建设的龙凤堂中药项目,将致力于药材自动化前处理——智能投料——原辅料、成品无人输送——机器人码垛——自动控温立体高架库储存等技术攻尖,全力打造现代化中药智能工厂。

集团发展不忘回报社会,多年来在赈灾、扶贫、拥军、助学以及各种人道主义救助活动中始终走在全社会的前列。集团至今连续16多年资助“中华医学科技奖”评选,鼎力支持祖国医学科技进步。汶川大地震发、天津港爆炸、盐城龙卷风灾害发生后,扬子江在第一时间捐赠款物,奉献爱心。

面向未来,奋进中的扬子江药业集团以振兴民族医药为己任,怀着科学、严谨、负责的态度,竭诚为全人类的健康服务。


Founded in 1971, Yangzijiang Pharmaceutical Group, an innovative pharmaceutical enterprise group with the integration of production, research, science, industry and trade, is a large-scale national pharmaceutical enterprise group with the integration of science, industry and trade and the combination of production, research and research. Headquartered in Taizhou City, Jiangsu Province, the group has 15000 employees and covers an area of more than 3 million square meters. Its 15 member companies are distributed in Taizhou, Beijing, Shanghai, Nanjing, Guangzhou, Chengdu, Suzhou, Changzhou and other places; the marketing network covers all provinces, cities and autonomous regions except Taiwan. Yangzijiang Pharmaceutical Group takes R & D and innovation as the strategic basis of enterprise development, and is committed to the R & D of national first-class new drugs and innovative drugs. The Group continues to take the road of innovation. In terms of new drug research and development, the group comprehensively promotes the strategy of "three drugs simultaneously". It invests in new drug research and development at the proportion of 3-4% of sales every year, seizes the commanding point of science and technology, introduces high-end R & D and innovation talents with international vision, and establishes an international R & D system. At present, more than 100 chemical innovative drugs, generic drugs, traditional Chinese medicine and biological drugs are under research, ensuring the orderly development of short-term, medium-term and long-term products. After years of accumulation and innovation, the product system covers more than 10 fields, more than 10 dosage forms and more than 200 product specifications. The group has always been market-oriented. Its R & D products mainly focus on anti infection, cardio cerebrovascular and digestive system, and actively explore other drug markets with growth potential, forming a product echelon of "R & D, production and storage", which effectively ensures the sustainable and healthy development of the enterprise. The group has successfully developed and listed a large number of excellent TCM products with unique curative effects, such as Weisu granule, bieling Weitong granule, Lanqin oral liquid, Shuanghua Lily tablet, Xiangshao granule, bailemining capsule, Huangqi essence oral liquid, chaiqinqingning capsule, qingruxiao granule, Bushen Runfei oral liquid, Shenqu Xiaoshi oral liquid, according to the prescription of famous old TCM, such as academician Dong Jianhua, the leader of traditional Chinese medicine Countless patients sent health gospel. The longfengtang traditional Chinese medicine project under construction will focus on the technology of automatic pre-processing of traditional Chinese Medicine - Intelligent feeding - raw and auxiliary materials, unmanned transportation of finished products - robot stacking - automatic temperature control three-dimensional elevated warehouse storage, and strive to build a modern intelligent factory of traditional Chinese medicine. The development of the group does not forget to repay the society, and it has always been in the forefront of the whole society in disaster relief, poverty alleviation, supporting the army, education and various humanitarian relief activities for many years. The group has supported the selection of "Chinese medical science and Technology Award" for more than 16 years in a row, making great efforts to support the progress of medical science and technology in China. After the Wenchuan earthquake, Tianjin Port explosion and Yancheng tornado disaster, the Yangtze River donated money and goods for the first time. Facing the future, the striving Yangtze River Pharmaceutical Group takes the rejuvenation of national medicine as its own duty, with a scientific, rigorous and responsible attitude, and wholeheartedly serves the health of all mankind.

本文链接: https://brand.waitui.com/4682ce224.html 联系电话:052386961999

千城特选小程序码

7×24h 快讯

比亚迪否认与蔚来汽车成立合资公司

11月22日,比亚迪集团品牌及公关处总经理李云飞表示,网传比亚迪与蔚来汽车相关的投资及合作信息,为严重不实信息。今日网络有传言称,比亚迪与蔚来将合作成立比未来汽车集团。(第一财经)

2小时前

亚马逊明年或面临欧盟《数字市场法案》相关调查

据路透消息,知情人士称,亚马逊明年可能面临欧盟《数字市场法案》(DMA)相关调查,涉及该公司是否于其在线市场上偏袒自有品牌产品。据透露,欧盟即将上任的反垄断负责人特雷莎·里韦拉(Teresa Ribera)将在未来几个月内决定是否启动调查。里韦拉将于下月上任,接替即将离任的玛格丽特·维斯塔格。(界面)

2小时前

电投产融:拟投建国家电投大连市花园口Ⅰ、Ⅱ海上风电项目

36氪获悉,电投产融发布公告,国家电投大连市花园口Ⅰ海上风电项目于2024年1月30日取得大连市发展和改革委员会核准批复意见,拟于近期开工建设,项目总投资18.98亿元。国家电投大连市花园口Ⅱ海上风电项目于2023年11月10日取得大连市发展和改革委员会核准批复意见,拟于近期开工建设,项目总投资21.81亿元。

2小时前

中国证券业协会召开股权与另类投资业务专业委员会全体会议

2024年11月14日,中国证券业协会在江苏南京召开股权与另类投资业务专业委员会全体会议。会议强调,行业机构要认真履职,树立并坚持理性投资、价值投资、长期投资的理念,以契合金融“五篇大文章”为主要目标选择投资标的,发挥证券公司在创业投资和私募股权投资方面的主力军、排头兵作用,加强投资过程管理,注重维护和保障投资者的利益,避免资金“脱实向虚”,为推动实体经济发展、优化资源配置、支持科技创新等做出更大贡献。(证券时报)

2小时前

DHL快递与壳牌签署合作协议

11月22日,DHL快递宣布与壳牌(Shell)签署协议,这项为期一年的协议包括通过输送管道向布鲁塞尔机场运送2.5万吨经国际可持续发展和碳认证(International Sustainability and Carbon Certification,即ISCC)体系认证的可持续航空燃料。(界面)

2小时前

本页详细列出关于天佑的品牌信息,含品牌所属公司介绍,天佑所处行业的品牌地位及优势。
咨询